SCHEMBL28650588

SCHEMBL28650588

CP(C)c1c(Nc2nc(Nc3ccc(F)c([N+](=O)[O-])c3)ncc2Cl)ccc2nccnc12

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 2/20 0.40
STK17A Q9UEE5 2/20 0.38
STK17B O94768 1/20 0.38
ALK Q9UM73 2/20 0.37
ABCG2 Q9UNQ0 2/20 0.37
ARNT P27540 2/20 0.37
EPAS1 Q99814 2/20 0.37
MAPK9 P45984 3/20 0.36
MAPK10 P53779 3/20 0.36
MAPK3 P27361 1/20 0.36
ULK1 O75385 1/20 0.36
CTSC P53634 2/20 0.36
CCNA2 P20248 2/20 0.36
CDK2 P24941 2/20 0.36
CCNK O75909 1/20 0.36
CDK9 P50750 1/20 0.36
MEN1 O00255 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
MAPT P10636 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30948628 1.00 BRD4 (0.40) BRD4STK17ASTK17BALKABCG2
SCHEMBL29253659 0.90 CDK1 (0.41) STK17AABCG2CDK2MEN1CYP1A2
SCHEMBL30948587 0.90 CDK1 (0.41) STK17AABCG2CDK2MEN1CYP1A2
SCHEMBL30948609 0.89 ABCG2 (0.41) BRD4STK17ASTK17BALKABCG2
SCHEMBL28649541 0.86 EGFR (0.47) BRD4STK17ASTK17BALKULK1
SCHEMBL22520159 0.81 EGFR (0.44) BRD4ALKMAPK9MAPK10
SCHEMBL28665507 0.81 MAPK9 (0.46) BRD4ALKMAPK9MAPK10ULK1
SCHEMBL28667884 0.79 EGFR (0.42) BRD4ALKABCG2ULK1CCNA2
SCHEMBL28650090 0.76 EGFR (0.48)
SCHEMBL30833749 0.75 MAPK9 (0.47) BRD4STK17ASTK17BALKABCG2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113677680-A EGFR inhibitor and composition and application thereof 贝达药业股份有限公司 2021-11-19 CN disclosed